These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37112935)

  • 1. Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers.
    Cortés-Sarabia K; Palomares-Monterrubio KH; Velázquez-Moreno JO; Luna-Pineda VM; Leyva-Vázquez MA; Vences-Velázquez A; Dircio-Maldonado R; Del Moral-Hernández O; Illades-Aguiar B
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers.
    Cortés-Sarabia K; Guzman-Silva V; Martinez-Pacheco KM; Meza-Hernández JA; Luna-Pineda VM; Leyva-Vázquez MA; Vences-Velázquez A; Beltrán-Anaya FO; Del Moral-Hernández O; Illades-Aguiar B
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112946
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
    Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
    Maina D; Omuse G; Ong'ete G; Mugaine P; Sayed S; Moloo Z; Shah R; Etyang A; Adam R
    PLoS One; 2022; 17(10):e0267619. PubMed ID: 36301926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity.
    Korobova ZR; Zueva EV; Arsentieva NA; Batsunov OK; Liubimova NE; Khamitova IV; Kuznetsova RN; Rubinstein AA; Savin TV; Stanevich OV; Kulikov AN; Pevtsov DE; Totolian AA
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain.
    Pérez-Olmeda M; Saugar JM; Fernández-García A; Pérez-Gómez B; Pollán M; Avellón A; Pastor-Barriuso R; Fernández-de Larrea N; Martín M; Cruz I; Sanmartín JL; Fedele G; Paniagua JL; Muñoz-Montalvo JF; Blanco F; Yotti R; Oteo-Iglesias J;
    J Clin Virol; 2022 Apr; 149():105130. PubMed ID: 35305377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
    Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Kumar MS; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Turuk A; Asthana S; Balachandar R; Bangar SD; Bansal AK; Chopra V; Das D; Deb AK; Devi KR; Dhikav V; Dwivedi GR; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Rangaraju C; Turuk J; Yadav R; Andhalkar R; Arunraj K; Bharadwaj DK; Bharti P; Bhattacharya D; Bhat J; Chahal AS; Chakraborty D; Chaudhury A; Deval H; Dhatrak S; Dayal R; Elantamilan D; Giridharan P; Haq I; Hudda RK; Jagjeevan B; Kalliath A; Kanungo S; Krishnan NN; Kshatri JS; Kumar A; Kumar N; Kumar VGV; Lakshmi GGJN; Mehta G; Mishra NK; Mitra A; Nagbhushanam K; Nimmathota A; Nirmala AR; Pandey AK; Prasad GV; Qurieshi MA; Reddy SD; Robinson A; Sahay S; Saxena R; Sekar K; Shukla VK; Singh HB; Singh PK; Singh P; Singh R; Srinivasan N; Varma DS; Viramgami A; Wilson VC; Yadav S; Yadav S; Zaman K; Chakrabarti A; Das A; Dhaliwal RS; Dutta S; Kant R; Khan AM; Narain K; Narasimhaiah S; Padmapriyadarshini C; Pandey K; Pati S; Patil S; Rajkumar H; Ramarao T; Sharma YK; Singh S; Panda S; Reddy DCS; Bhargava B;
    Int J Infect Dis; 2021 Jul; 108():145-155. PubMed ID: 34022338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
    Lumley SF; Wei J; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Peck LJ; Ritter TG; de Toledo Z; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Crook DW; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Walker TM; Jeffery K; Eyre DW;
    Clin Infect Dis; 2021 Aug; 73(3):e699-e709. PubMed ID: 33400782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France.
    Garlantezec R; Tadié E; Heslan C; Gary-Bobo P; Oumari S; Saade A; Sitruk A; Tattevin P; Thibault V; Paris C;
    Infect Dis Now; 2022 Nov; 52(8):447-452. PubMed ID: 36108975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
    Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D;
    Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study.
    Mehboob S; Rehman A; Haq M; Rajab H; Haq M; Haq H; Ahmad J; Ahmad S; Abbas M; Anwar S; Haq N
    Ir J Med Sci; 2023 Apr; 192(2):915-918. PubMed ID: 35412213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico.
    Rodríguez-Vidales EP; Garza-Carrillo D; Pérez-Trujillo JJ; Robles-Rodríguez OA; Salinas-Martínez AM; Montes de Oca-Luna R; Treviño-Garza C; De la O-Cavazos ME
    J Med Virol; 2021 Oct; 93(10):5873-5879. PubMed ID: 34101203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening.
    Srivastava AK; Gupta A; Chauhan D; Meena RC; Sugadev R; Eslavath MR; Gupta H; Karuna ; Singh S; Singh Y; Tiwari RP; Kohli V; Varshney R; Ganju L
    Appl Microbiol Biotechnol; 2022 Sep; 106(18):6225-6238. PubMed ID: 35976427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.